Metlife (NYSE:MET) Price Target Cut to $53.00
Metlife (NYSE:MET) had its price objective decreased by investment analysts at Morgan Stanley from $54.00 to $53.00 in a research note issued to investors on Tuesday, BenzingaRatingsTable reports. The firm presently has an “equal weight” rating on the financial services provider’s stock. Morgan Stanley’s target price suggests a potential upside of 15.82% from the stock’s previous close.
MET has been the subject of several other reports. Zacks Investment Research upgraded Metlife from a “sell” rating to a “hold” rating and set a $51.00 target price for the company in a research note on Friday, August 2nd. Citigroup set a $42.00 price target on Metlife and gave the company a “sell” rating in a research note on Thursday, May 23rd. ValuEngine downgraded Metlife from a “hold” rating to a “sell” rating in a research note on Thursday, August 1st. Barclays lifted their price target on Metlife from $52.00 to $55.00 and gave the company an “overweight” rating in a research note on Wednesday, May 22nd. Finally, Wells Fargo & Co lifted their price target on Metlife from $55.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, July 11th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $49.71.
MET stock opened at $45.76 on Tuesday. The stock has a 50-day moving average price of $48.66 and a 200-day moving average price of $46.68. Metlife has a 1-year low of $37.76 and a 1-year high of $51.16. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.22. The firm has a market cap of $42.47 billion, a PE ratio of 8.49, a price-to-earnings-growth ratio of 0.96 and a beta of 1.09.
A number of hedge funds have recently modified their holdings of the business. Cresset Asset Management LLC increased its holdings in shares of Metlife by 18.7% in the second quarter. Cresset Asset Management LLC now owns 4,475 shares of the financial services provider’s stock worth $222,000 after purchasing an additional 705 shares during the period. Colony Group LLC bought a new position in shares of Metlife in the second quarter worth $1,088,000. One Wealth Advisors LLC increased its holdings in shares of Metlife by 4.8% in the second quarter. One Wealth Advisors LLC now owns 16,629 shares of the financial services provider’s stock worth $826,000 after purchasing an additional 765 shares during the period. Ladenburg Thalmann Financial Services Inc. increased its holdings in shares of Metlife by 7.6% in the second quarter. Ladenburg Thalmann Financial Services Inc. now owns 77,427 shares of the financial services provider’s stock worth $3,853,000 after purchasing an additional 5,436 shares during the period. Finally, MAI Capital Management increased its holdings in shares of Metlife by 12.1% in the second quarter. MAI Capital Management now owns 184,611 shares of the financial services provider’s stock worth $9,170,000 after purchasing an additional 19,927 shares during the period. 76.14% of the stock is currently owned by institutional investors and hedge funds.
Metlife Company Profile
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Featured Story: Google Finance Portfolio Tips and Tricks
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.